Market Place
Sourcing Support
Aurobindo Pharma Generic Ambrisentan Receives Approval in the U.S.
21 Jul 2022 //
FDA
Altavant Presents Data Showing on Combination Of Rodatristat Ethyl+Ambrisentan
06 May 2022 //
PRNEWSWIRE
FDA Explains Why it Waived a Shared REMS for Letairis Generics
06 May 2019 //
RAPS
Watson Labs Generic Ambrisentan Receives Approval in US
30 Mar 2019 //
FDA
Mylan Pharms Generic Ambrisentan Approval in US
30 Mar 2019 //
FDA
Zydus Pharms USA`s Generic Ambrisentan Receives Approval in US
30 Mar 2019 //
FDA
Sun Pharms INDS Generic Ambrisentan Receives Approval in US
30 Mar 2019 //
FDA
Drugmakers Cancel Price Hikes After California Law Takes Effect
12 Jul 2018 //
BLOOMBERG
FDA Calls Out Pharma Cos for Blocking Requests from Generic Manufacturers
18 May 2018 //
BIOSPACE
GSK earns expanded approval for Volibris in Europe
26 Nov 2015 //
PM LIVE
Gilead (GILD) Scores FDA Approval of Letairis Combo as PAH Treatment
06 Oct 2015 //
BIOSPACE
Gilead and GSK pulmonary hypertension drugs work in tandem
28 Aug 2015 //
PM LIVE
Actavis Confirms Generic Letairis® Patent Challenge
04 Apr 2015 //
ACTAVIS
"GSK Seeks EU Marketing Nod to Use Ambrisentan`s Extended Indication to Treat PAH "
11 Dec 2014 //
PHARMABIZ.COM
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.